Date

 

 

 

Search Results

Showing 1 - 5 of 5
Sort by: Newest first | Best match

CMS ANNOUNCES PROPOSED PAYMENT UPDATE AND POLICY CHANGES FOR MEDICARE PHYSICIAN FEE SCHEDULE

The Centers for Medicare & Medicaid Services (CMS) expects to pay approximately $56.5 billion to 875,000 physicians and other health care professionals in 2006, according to a proposed rule released today that would update payment rates and revise payment policies under the Medicare Physician Fee Schedule.
Press Release

CMS PROPOSES POLICY CHANGES AND PAYMENT UPDATES FOR DIALYSIS FACILITIES IN 2012

The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule that would update Medicare policies and payment rates for 5,304 dialysis facilities paid under a new bundled Prospective Payment System (PPS) that was implemented in calendar year (CY) 2011.
Press Release

CMS PROPOSES POLICY, PAYMENT RATE CHANGES FOR SERVICES IN HOSPITAL OUTPATIENT DEPARTMENTS AND

Hospitals would be able to bill Medicare for pulmonary and intensive cardiac rehabilitation services furnished in outpatient departments beginning January 1, 2010 under a proposed rule issued today by the Centers for Medicare & Medicaid Services (CMS).
Press Release

MEDICARE LAUNCHES MISSISSIPPI HEALTH FIRST COLLABORATIVE FOR DIABETES CARE IN COMMUNITY SETTINGS

A statewide effort to improve care for patients with diabetes across Mississippi, particularly for patients considered to be “medically underserved ,” is being announced today by the Centers for Medicare & Medicaid Services (CMS).  The initiative is called the Mississippi Health First Collaborative.
Press Release

MEDICARE ISSUES PROPOSED COVERAGE DECISION ON ERYTHROPOESIS STIMULATING AGENTS

The Centers for Medicare & Medicaid Services (CMS) announced today its proposed decision to limit coverage of erythropoiesis stimulating agent (ESA) treatment for beneficiaries with certain cancers and related neoplastic conditions, either because of a deleterious effect of the ESA on the beneficiaries’ underlying disease or because the underlying disease increases their risk of adverse effects related to ESA use.
Press Release